Results 71 to 80 of about 51,402 (230)

Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams   +3 more
wiley   +1 more source

A unique overlap of scarring and non-scarring alopecia in primary cutis verticis gyrata

open access: yes
Cutis verticis gyrata (CVG) is a rare scalp disorder characterized by cerebriform thickening and folding of the scalp skin. It can present as a primary essential form without underlying systemic involvement.

core   +1 more source

In vivo differentiation of scarring alopecia using line‐field confocal optical coherence tomography: a pilot study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives: Diagnosing cicatricial alopecia is challenging. Even with histology, a definitive diagnosis cannot always be made. Line‐field confocal optical coherence tomography (LC‐OCT), a non‐invasive imaging method with high resolution used in vivo, has proven helpful in diagnosing scarring alopecia.
Marie‐Christine Nutz   +5 more
wiley   +1 more source

DataSheet_2_Association between genetically predicted leukocyte telomere length and non-scarring alopecia: A two-sample Mendelian randomization study.pdf

open access: yes, 2023
BackgroundThe most commonly acknowledged non-scarring alopecia are androgenetic alopecia (AGA) and alopecia areata (AA). Previous studies have revealed various risk factors associated with alopecia.
Minjun Liao (11080362)   +7 more
core   +1 more source

Quality of life and psychosocial impact of scarring and non-scarring alopecia in women [Lebensqualität und psychosoziale Folgen der vernarbenden und der nicht-vernarbenden Alopezie bei Frauen]

open access: yes, 2015
Background Alopecia is a common dermatological condition with mostly cosmetic consequences that, nevertheless, has significant psychological and psychosocial impact.
Kaloudi, E.   +8 more
core   +1 more source

Consensus‐based Guideline on tinea capitis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The consensus‐based guideline developed under the auspices of the German Dermatological Society (DDG) is intended to provide physicians with a structured framework for clinical decision‐making in the management of patients with tinea capitis and to contribute to improved diagnostic accuracy, treatment adherence, and prevention. Tinea capitis is
Peter Mayser   +19 more
wiley   +1 more source

A Study of Non-Scarring Diffuse Alopecia [PDF]

open access: yes, 2018
Paucity of reports on non-scarring diffuse alopecia in women from this part of the world led us to take up this study. We examined 200 consecutive cases of non-scarring diffuse alopecia in women who attended the skin OPD of a tertiary level urban ...
Sagar, Vivek, Shrivastava, S B
core  

The Role of Vitamin D in Non-Scarring Alopecia

open access: yes, 2017
Non-scarring hair loss is a common problem that affects both male and female patients. Since any disturbances in the hair follicle cycle may lead to hair shedding, or alopecia, it is not surprising that the possible role of vitamin D in alopecia was ...
Agnieszka Gerkowicz   +3 more
core   +1 more source

Clinical and Trichoscopic Patterns of Discoid Lupus Erythematosus of Scalp in Patients with Systemic Lupus Erythematosus: An Observational Study

open access: yesIndian Journal of Dermatology
Background: Discoid lupus erythematosus (DLE) is a specific cutaneous manifestation of systemic lupus erythematosus (SLE), which results in scarring alopecia of the scalp.
Shivani Bhardwaj   +7 more
doaj   +1 more source

Congenital Sparse and Brittle Hair in a Child

open access: yes
JEADV Clinical Practice, EarlyView.
Sanket Bishokarma   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy